These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34517465)

  • 1. [Current status of nucleic acid testing for hepatitis C].
    Wang Y; Mao YR
    Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):803-806. PubMed ID: 34517465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in studies of HCV nucleic acid testing for clinical diagnosis].
    Xu B; He XX; Ren YN; Wang J; Xing WW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):153-159. PubMed ID: 33503713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnostics of hepatitis C virus infection: a systematic review.
    Scott JD; Gretch DR
    JAMA; 2007 Feb; 297(7):724-32. PubMed ID: 17312292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
    Takahashi M; Muraoka M; Tadokoro K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
    Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y
    Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy.
    Chen L; Li W; Zhang K; Zhang R; Lu T; Hao M; Jia T; Sun Y; Lin G; Wang L; Li J
    J Mol Diagn; 2016 Jan; 18(1):84-91. PubMed ID: 26612712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of hepatitis C virus RNA by a reverse transcription loop-mediated isothermal amplification assay.
    Wang QQ; Zhang J; Hu JS; Chen HT; Du L; Wu LQ; Ding YZ; Xiong SH; Huang XC; Zhang YH; Liu YS
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):144-7. PubMed ID: 21635570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic tests: Hepatitis C virus genome (HCV RNA)].
    Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():415-7. PubMed ID: 16111289
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications.
    Al Olaby RR; Azzazy HM
    Expert Rev Mol Diagn; 2011 Jan; 11(1):53-64. PubMed ID: 21171921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0.
    Germer JJ; Lins MM; Jensen ME; Harmsen WS; Ilstrup DM; Mitchell PS; Cockerill FR; Patel R
    J Clin Microbiol; 2003 Aug; 41(8):3503-8. PubMed ID: 12904346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nucleic acid-based testing for hepatitis C virus infection].
    Nomura F; Itoga S
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():338-41. PubMed ID: 16416815
    [No Abstract]   [Full Text] [Related]  

  • 17. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardized hepatitis C virus RNA panels for nucleic acid testing assays.
    Jorgensen PA; Neuwald PD
    J Clin Virol; 2001 Jan; 20(1-2):35-40. PubMed ID: 11163581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral HCV RNA reactivity of corneal cells in plasma HCV nucleic acid-positive eye donors.
    Heck E; Dingrando A; Proctor C; Cavanagh HD
    Cornea; 2013 Apr; 32(4):506-7. PubMed ID: 23086369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
    Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
    Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.